The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-next-gen-agent-mantle-cell-lymphoma-2026a1000fj5?src=rss
Author :
Publish date : 2026-05-13 20:36:00
Copyright for syndicated content belongs to the linked Source.
